Krebs Biochemicals and Industries Limited Financial Ratios
KREBSBIO · Healthcare · Current price ₹60.8
P/E ratio
-9.4x
P/B ratio
-0.8x
ROE
18.4%
ROCE
-15.9%
Debt / Equity
—
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | -9.4x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | -0.8x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 18.4% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | -15.9% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | — | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Krebs Biochemicals and Industries Limited's latest numbers.
Krebs Biochemicals and Industries Limited profitability
Krebs Biochemicals and Industries Limited generates a return on equity of 18.4% and a return on capital employed of -15.9%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of n/a and a P/E of -9.4x, Krebs Biochemicals and Industries Limited is conservatively financed. Our overall business-quality score for the company is 3.9 / 10.
Understand the ratios
More on Krebs Biochemicals and Industries Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.